Pharmacy Innovations recalls Ceftazidime Intravitreal (1ML vial) 22.5 MG/ML(2.25MG/0.1ML) Injectable, Rx Only, Pharmacy Innovations, 2936 W 17th St.,
Recalled February 1, 2023 · FDA recall D-0197-2023 · Pharmacy Innovations
Hazard
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility. · FDA Class II
Units
N/A
Sold at
Nationwide in the USA
Description
Lack of Assurance of Sterility: FDA inspection revealed insanitary conditions at the facility.
Product
Ceftazidime Intravitreal (1ML vial) 22.5 MG/ML(2.25MG/0.1ML) Injectable, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
Manufacturer(s)
Pharmacy Innovations
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →